Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma

Advances in the development of personalized neoantigen-based therapeutic cancer vaccines

(2021) Eryn Blass et al.   Nature Reviews Clinical Oncology

The immune microenvironment and neoantigen landscape of aggressive salivary gland carcinomas differ by subtype

(2020) Luc GT Morris et al.   CLINICAL CANCER RESEARCH

Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment

(2020) Masato Nakaguro et al.   CANCER CYTOPATHOLOGY

Antitumour dendritic cell vaccination in a priming and boosting approach

(2020) Alexandre Harari et al.   NATURE REVIEWS DRUG DISCOVERY

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

(2020) Patrick A. Ott et al.   CELL

Healthy Donors Harbor Memory T Cell Responses to RAS Neo-Antigens

(2020) Morten Orebo Holmström et al.   Cancers

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

(2019) Robert M. Samstein et al.   NATURE GENETICS

High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals

(2019) Morten O. Holmström et al.   Blood Cancer Journal

Trial watch: dendritic cell vaccination for cancer immunotherapy

(2019) Jenny Sprooten et al.   OncoImmunology

Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma

(2018) Roger B. Cohen et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies

(2018) Roberta Zappasodi et al.   CANCER CELL

Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens

(2018) Kazuma Kiyotani et al.   CANCER SCIENCE

Cancer Neoantigens

(2018) Ton N. Schumacher et al.   Annual Review of Immunology

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

(2018) Derin B. Keskin et al.   NATURE

Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands

(2017) Eline Boon et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

(2017) Ugur Sahin et al.   NATURE

An immunogenic personal neoantigen vaccine for patients with melanoma

(2017) Patrick A. Ott et al.   NATURE

Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?

(2017) Salvatore Alfieri et al.   ORAL ONCOLOGY

Trial watch: Dendritic cell-based anticancer immunotherapy

(2017) Abhishek D. Garg et al.   OncoImmunology

Integrated analysis of somatic mutations and immune microenvironment in malignant pleural mesothelioma

(2017) Kazuma Kiyotani et al.   OncoImmunology

Management of Salivary Gland Tumours: United Kingdom National Multidisciplinary Guidelines

(2016) S Sood et al.   JOURNAL OF LARYNGOLOGY AND OTOLOGY

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

(2016) N. McGranahan et al.   SCIENCE

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

(2016) Valsamo Anagnostou et al.   Cancer Discovery

Immune Checkpoint Blockade in Cancer Therapy

(2015) Michael A. Postow et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoantigens in cancer immunotherapy

(2015) T. N. Schumacher et al.   SCIENCE

A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells

(2015) B. M. Carreno et al.   SCIENCE

The future of immune checkpoint therapy

(2015) P. Sharma et al.   SCIENCE

OptiType: precision HLA typing from next-generation sequencing data

(2014) András Szolek et al.   BIOINFORMATICS